Immunomodulating and Immunoresistance Properties of Cancer-Initiating Cells: Implications for the Clinical Success of Immunotherapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Immunomodulating and Immunoresistance Properties of Cancer-Initiating Cells: Implications for the Clinical Success of Immunotherapy

Published:2017-03-13 Issue:3 Volume:46 Page:221-238
ISSN:0882-0139
Container-title:Immunological Investigations
language:en
Short-container-title:Immunological Investigations

Author:

Maccalli Cristina¹,Parmiani Giorgio²,Ferrone Soldano³

Affiliation:

1. Department of Translational Medicine, Sidra Medical and Research Center, Doha, Qatar

2. Italian Network for Biotherapy, University Hospital of Siena, Siena, Italy

3. Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA

Publisher

Informa UK Limited

Subject

General Medicine,Immunology

Link

https://www.tandfonline.com/doi/pdf/10.1080/08820139.2017.1280051

Reference62 articles.

1. Epithelial-mesenchymal transitions: the importance of changing cell state in development and disease

2. Multiple chimeric antigen receptors successfully target chondroitin sulfate proteoglycan 4 in several different cancer histologies and cancer stem cells

3. Bioactivity and Safety of IL13Rα2-Redirected Chimeric Antigen Receptor CD8+ T Cells in Patients with Recurrent Glioblastoma

4. Stem-like Tumor-Initiating Cells Isolated from IL13Rα2 Expressing Gliomas Are Targeted and Killed by IL13-Zetakine–Redirected T Cells

5. The Concept of Immunological Surveillance

Cited by 77 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analysis of Th1/Th2 cytokine profile and clinical characteristics of patients with head and neck squamous cell carcinoma;Biomolecules and Biomedicine;2024-06-24

2. Sulindac sulfide as a non-immune suppressive γ-secretase modulator to target triple-negative breast cancer;Frontiers in Immunology;2023-10-13

3. Understanding and Overcoming Immunosuppression Shaped by Cancer Stem Cells;Cancer Research;2023-07-05

4. Therapeutic targeting of dormant cancer stem cells in solid tumors;Gene Reports;2023-03

5. ROS, Redox Regulation, and Anticancer Therapy;Redox Regulation and Therapeutic Approaches in Cancer;2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3